Attar EC, Scadden DT. Regulation of hematopoietic stem cell growth. Leukemia. 2004. https://doi.org/10.1038/sj.leu.2403515.

Article  PubMed  Google Scholar 

Henig I, Zuckerman T. Hematopoietic stem cell transplantation-50 years of evolution and future perspectives. Rambam Maimonides Med J. 2014;5: e0028.

Article  PubMed  PubMed Central  Google Scholar 

Niederwieser D, Baldomero H, Bazuaye N, et al. One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors. Haematologica. 2022;107:1045–53.

Article  PubMed  Google Scholar 

Sutherland DR, Anderson L, Keeney M, et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematotherapy Stem Cell Res. 1996;5:213–26.

CAS  Google Scholar 

Bilgin YM. Use of plerixafor for stem cell mobilization in the setting of autologous and allogeneic stem cell transplantations: an update. J Blood Med. 2021;12:403–12.

Article  PubMed  PubMed Central  Google Scholar 

Abrahamsen JF, Stamnesfet S, Liseth K, et al. Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells. Transfusion. 2005;45:248–53.

Article  CAS  PubMed  Google Scholar 

Lee G, Arepally GM. Anticoagulation techniques in apheresis: from heparin to citrate and beyond. J Clin Apher. 2012;27:117–25.

Article  PubMed  PubMed Central  Google Scholar 

Blood donor selection: guidelines on assessing donor suitability for blood donation. 2012.

Stoikou M, van Breda SV, Schäfer G, et al. G-CSF infusion for stem cell mobilization transiently increases serum cell-free DNA and protease concentrations. Front Med. 2020;7:155.

Article  Google Scholar 

Bazinet A, Popradi G. A general practitioner’s guide to hematopoietic stem-cell transplantation. Curr Oncol. 2019;26:187–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yahng S-A, Lee JW, Kim Y, et al. New proposed guidelines for early identification of successful myeloid and erythroid engraftment in hematopoietic stem cell transplantation. J Clin Lab Anal. 2014;28:469–77.

Article  PubMed  PubMed Central  Google Scholar 

Carrega P, Ferlazzo G. Natural killer cell distribution and trafficking in human tissues. Front Immunol. 2012;3:347.

Article  PubMed  PubMed Central  Google Scholar 

Atkinson K, Horowitz MM, Gale RP, et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood. 1990;75:2459–64.

Article  CAS  PubMed  Google Scholar 

Impola U, Larjo A, Salmenniemi U, et al. Graft immune cell composition associates with clinical outcome of allogeneic hematopoietic stem cell transplantation in patients with AML. Front Immunol. 2016;7:523.

Article  PubMed  PubMed Central  Google Scholar 

Maggs L, Kinsella F, Chan YLT, et al. The number of CD56dim NK cells in the graft has a major impact on risk of disease relapse following allo-HSCT. Blood Adv. 2017;1:1589–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Minculescu L, Marquart HV, Ryder LP, et al. Improved overall survival, relapse-free-survival, and less graft-vs.-host-disease in patients with high immune reconstitution of TCR gamma delta cells 2 months after allogeneic stem cell transplantation. Front Immunol. 2019;10:1997.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Danby RD, Zhang W, Medd P, et al. High proportions of regulatory T cells in PBSC grafts predict improved survival after allogeneic haematopoietic SCT. Bone Marrow Transplant. 2016;51:110–8.

Article  CAS  PubMed  Google Scholar 

Amsen D. T cells take directions from supporting cast in graft-versus-host disease. J Clin Invest. 2017;127:1215–7.

Article  PubMed  PubMed Central  Google Scholar 

Loschi M, Porcher R, Peffault de Latour R, et al. High number of memory t cells is associated with higher risk of acute graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2015;21:569–74.

Article  CAS  PubMed  Google Scholar 

Giralt S, Costa L, Schriber J, et al. Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations. Biol Blood Marrow Transplant. 2014;20:295–308.

Article  PubMed  Google Scholar 

Carral A, de la Rubia J, Martín G, et al. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies. Bone Marrow Transplant. 2002;29:825–32.

Article  CAS  PubMed  Google Scholar 

Sumransub N, Cao Q, Wangen R, et al. High proliferating regulatory T cells post-transplantation are associated with poor survival in lymphoma patients treated with autologous hematopoietic stem cell transplantation. Transplant Cell Ther. 2022;28:184.e1-184.e8.

Article  CAS  PubMed  Google Scholar 

Nahi H, Chrobok M, Meinke S, et al. Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma. Cell reports Med. 2022;3: 100508.

Article  CAS  Google Scholar 

Martino M, Paviglianiti A, Memoli M, et al. Multiple myeloma outpatient transplant program in the era of novel agents: state-of-the-art. Front Oncol. 2020;10: 592487.

Article  PubMed  PubMed Central  Google Scholar 

Charalampous C, Goel U, Kapoor P, et al. Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy. Blood Adv. 2023;7:4371–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Derman BA, Kansagra A, Zonder J, et al. Elotuzumab and weekly carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma without transplant intent: a phase 2 measurable residual disease-adapted study. JAMA Oncol. 2022;8:1278–86.

Article  PubMed  PubMed Central  Google Scholar 

Al Hamed R, Bazarbachi AH, Malard F, et al. Current status of autologous stem cell transplantation for multiple myeloma. Blood Cancer J. 2019;9:44.

Article  PubMed  PubMed Central  Google Scholar 

Barrett AJ, Longhurst P, Sneath P, et al. Mobilization of CFU-C by exercise and ACTH induced stress in man. Exp Hematol. 1978;6(7):590–594

CAS  PubMed  Google Scholar 

Turner JE, Wadley AJ, Aldred S, et al. Intensive exercise does not preferentially mobilize skin-homing T cells and NK cells. Med Sci Sports Exerc. 2016. https://doi.org/10.1249/MSS.0000000000000914.

Article  PubMed  Google Scholar 

Anane LH, Edwards KM, Burns VE, et al. Mobilization of gammadelta T lymphocytes in response to psychological stress, exercise, and beta-agonist infusion. Brain Behav Immun. 2009;23:823–9.

Article  CAS  PubMed  Google Scholar 

Bogataj Š, Pajek J, Buturović Ponikvar J, et al. Functional training added to intradialytic cycling lowers low-density lipoprotein cholesterol and improves dialysis adequacy: a randomized controlled trial. BMC Nephrol. 2020;21:352.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Graham-Brown MPM, March DS, Young R, et al. A randomized controlled trial to investigate the effects of intra-dialytic cycling on left ventricular mass. Kidney Int. 2021;99:1478–86.

Article  PubMed  Google Scholar 

March DS, Hurt AW, Grantham CE, et al. A cost-effective analysis of the CYCLE-HD randomized controlled trial. Kidney Int reports. 2021;6:1548–57.

Article